PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Phone561-526-4444
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$283.42 million
Profitability
Miscellaneous
Employees187
Next Earnings Date7/22/2019 (Estimated)
OptionableOptionable
Petmed Express (NASDAQ:PETS) Frequently Asked Questions
What is Petmed Express' stock symbol?
Petmed Express trades on the NASDAQ under the ticker symbol "PETS."
How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?
Petmed Express declared a quarterly dividend on Monday, May 6th. Investors of record on Friday, May 17th will be given a dividend of $0.27 per share on Friday, May 24th. This represents a $1.08 dividend on an annualized basis and a yield of 5.93%. The ex-dividend date is Thursday, May 16th. View Petmed Express' Dividend History.
How were Petmed Express' earnings last quarter?
Petmed Express Inc (NASDAQ:PETS) issued its quarterly earnings data on Monday, May, 6th. The company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.46 by $0.14. The business had revenue of $64.57 million for the quarter, compared to analyst estimates of $69.06 million. Petmed Express had a return on equity of 28.96% and a net margin of 13.32%. The company's quarterly revenue was down 4.1% compared to the same quarter last year. During the same period last year, the firm posted $0.50 earnings per share. View Petmed Express' Earnings History.
When is Petmed Express' next earnings date?
What price target have analysts set for PETS?
2 Wall Street analysts have issued 12-month target prices for Petmed Express' shares. Their predictions range from $18.00 to $18.00. On average, they expect Petmed Express' stock price to reach $18.00 in the next year. This suggests that the stock has a possible downside of 1.2%. View Analyst Price Targets for Petmed Express.
What is the consensus analysts' recommendation for Petmed Express?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.
Has Petmed Express been receiving favorable news coverage?
Press coverage about PETS stock has trended negative on Sunday, InfoTrie reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Petmed Express earned a daily sentiment score of -2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the company's share price in the near future.
Who are some of Petmed Express' key competitors?
What other stocks do shareholders of Petmed Express own?
Who are Petmed Express' key executives?
Petmed Express' management team includes the folowing people:
- Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
- Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
- Ms. Alison Berges, Corp. Sec. & Gen. Counsel
Who are Petmed Express' major shareholders?
Petmed Express' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.91%), Renaissance Technologies LLC (8.01%), Dimensional Fund Advisors LP (4.33%), Morgan Stanley (4.29%), LSV Asset Management (3.69%) and River Road Asset Management LLC (2.20%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.
Which major investors are selling Petmed Express stock?
PETS stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Goldman Sachs Group Inc., Renaissance Technologies LLC, AQR Capital Management LLC, Morgan Stanley, Penserra Capital Management LLC, Parametric Portfolio Associates LLC and JPMorgan Chase & Co.. Company insiders that have sold Petmed Express company stock in the last year include Frank J Formica and Robert C Schweitzer. View Insider Buying and Selling for Petmed Express.
Which major investors are buying Petmed Express stock?
PETS stock was acquired by a variety of institutional investors in the last quarter, including Oxford Asset Management LLP, LSV Asset Management, Sio Capital Management LLC, Rothschild Investment Corp IL, Man Group plc, Hotchkis & Wiley Capital Management LLC, Hotchkis & Wiley Capital Management LLC and GYL Financial Synergies LLC. View Insider Buying and Selling for Petmed Express.
How do I buy shares of Petmed Express?
Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Petmed Express' stock price today?
One share of PETS stock can currently be purchased for approximately $18.22.
How big of a company is Petmed Express?
Petmed Express has a market capitalization of $376.68 million and generates $283.42 million in revenue each year. Petmed Express employs 187 workers across the globe.
What is Petmed Express' official website?
How can I contact Petmed Express?
Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.
MarketBeat Community Rating for Petmed Express (NASDAQ PETS)
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
